Nafarelin
Synarel (nafarelin) is a protein pharmaceutical. Nafarelin was first approved as Synarel on 1990-02-13. It is used to treat endometriosis and precocious puberty in the USA. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
Trade Name | Synarel |
---|---|
Common Name | Nafarelin |
Indication | endometriosis, precocious puberty |
Drug Class | Prehormones or hormone-release stimulating peptides |